BTCY — BIOTRICITY INC.

OTC · Health Care · Health Care Equipment & Supplies · CIK 1630113 ·
Last close
$0.14
Market Cap
$4.07M
52W High
$0.30
52W Low
$0.10
ADV30
107,690
Next earnings
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes wet electrodes for cardiac outpatient monitoring (COM) market; Biocore, a Holter and Extended Holter monitors for cardiac diagnostics; Biocare which support medical practitioners to gather data, and regularly monitor and treat patients with two or more chronic care conditions; Bioheart that offers preventative care and disease management solutions; and Biokit, a remote patient monitoring kit for cardiac patients that had other chronic conditions such as hypertension or COPD. Biotricity, Inc. is based in Redwood City, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 3,987,819 3,251,476 440,915 -717,067 5,686,495 256,357 38,208,764
Sep 2025 3,885,795 3,181,498 273,819 -690,913 6,322,772 308,460 37,984,860
Jun 2025 3,873,993 3,116,800 281,945 -671,977 6,037,319 391,292 36,835,946
Mar 2025 3,702,597 2,978,181 -855,466 -1,935,737 5,640,954 365,145 35,655,054

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,098,835
Investing CF
$0
Financing CF
$814,303
CapEx
Dividends Paid
$-24,149
Buybacks
$0
EPS Diluted TTM
$-0.15
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-142,116,468
Inventory
$1,974,758
Receivables
$2,750,124
ST Investments
EBIT TTM
$102,325
Pretax Income TTM
$-4,015,694
Interest Exp TTM
$4,118,019
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$15,450,204
EBITDA
$147,166
Free Cash Flow
$379,275
Enterprise Value
$32,235,504
Total Cash
$1,428,212
Total Debt
$27,086,154
Shares Out
28,436,643
Trailing EPS
$-0.16
Book Value
$-1.22
ROE
ROA
1.5%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2025 13,790,294 -2,448,966 -8,421,179 5,640,954 35,655,054 -2,380,177
Mar 2024 12,063,345 -8,828,269 -14,094,283 5,942,625 35,919,442 -6,693,912
Mar 2023 9,639,057 -15,409,711 -18,658,143 6,510,544 26,355,929 -13,547,935
Mar 2022 7,650,269 -16,736,803 -29,130,477 16,677,970 18,822,706 -15,163,384

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.43

Peers — same industry

TickerNameMarket CapLastDaily %
TUTH Standard Dental Labs Inc. $3.88M $0.12
AEMD AETHLON MEDICAL INC $3.84M $2.45
GCTK Glucotrack, Inc. $3.72M $0.59
SNOA Sonoma Pharmaceuticals, Inc. $3.68M $1.06
AMIX Autonomix Medical, Inc. $4.77M $0.42

News headlines (Yahoo Finance, 1h cache)

Biotricity, Inc to Present at the LD Micro Invitational XVI
2026-05-12 12:15 · Yahoo
Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...
2026-02-12 05:02 · Yahoo
Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA
2026-02-11 21:00 · Yahoo
Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th
2026-02-05 21:15 · Yahoo
The Zacks Analyst Blog Highlights Hims & Hers Health, Biotricity and Privia Health
2025-12-24 14:58 · Yahoo
3 Healthcare IT Stocks Up More Than 20% in 2025 With More Room to Run
2025-12-23 19:08 · Yahoo
Biotricity Inc (BTCY) Q2 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion
2025-11-15 05:00 · Yahoo
Biotricity Inc. (BTCY) Reports Q2 Loss, Lags Revenue Estimates
2025-11-14 22:00 · Yahoo
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
2025-11-14 21:00 · Yahoo
Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates
2025-11-13 14:40 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.